HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients.

Abstract
The study aimed to assess the clinical utility in identifying CIN2 or worse (CIN2+), of the Pretect HPV-Proofer test for E6/E7 mRNA detection in Hybrid Capture 2 (HC2)-positive patients, who underwent colposcopy. In particular, the study analyzed the mRNA test performance as the third test in a subgroup of HC2+ patients with less severe than high-grade squamous intraepithelial lesions (HSIL-). We analyzed 464 cervico-vaginal samples by liquid-based cytology (LBC) and PreTect HPV-Proofer. Moreover 231 patients also had a biopsy at baseline and 75, with HSIL-, were followed up within 2 years by LBC, colposcopy, and histology when indicated. The highest sensitivity for CIN2+ belonged to the mRNA compared to LBC, at the HSIL+ threshold (72% vs. 58%), whereas the LBC showed the highest specificity and positive predictive value (PPV) (99 and 93% vs. 73 and 39%, respectively). Focusing on the 408 HSIL- patients, the mRNA positivity was significantly more associated with CIN2+ than CIN2- lesions (p < 0.0001). Moreover, among the 75 HSIL- followed up patients, the mRNA displayed high longitudinal Specificity (89%), even if the sensitivity and the PPV were low (50 and 20%, respectively). The present data suggest that the mRNA test may have a diagnostic and a potentially prognostic role in HC2+/HSIL- patients.
AuthorsMaria Benevolo, Irene Terrenato, Marcella Mottolese, Ferdinando Marandino, Mariantonia Carosi, Francesca Rollo, Livia Ronchetti, Paola Muti, Luciano Mariani, Stefano Sindico, Giuseppe Vocaturo, Amina Vocaturo
JournalCancer causes & control : CCC (Cancer Causes Control) Vol. 22 Issue 6 Pg. 869-75 (Jun 2011) ISSN: 1573-7225 [Electronic] Netherlands
PMID21424209 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • E6 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • RNA, Messenger
  • RNA, Viral
  • Repressor Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Cervix Uteri (metabolism, pathology, virology)
  • Cytodiagnosis (methods)
  • Diagnostic Techniques, Obstetrical and Gynecological
  • Female
  • Humans
  • Middle Aged
  • Oncogene Proteins, Viral (genetics, isolation & purification)
  • Papillomavirus E7 Proteins (genetics, isolation & purification)
  • Papillomavirus Infections (diagnosis, pathology, virology)
  • Predictive Value of Tests
  • Prognosis
  • RNA, Messenger (isolation & purification)
  • RNA, Viral (isolation & purification)
  • Repressor Proteins (genetics, isolation & purification)
  • Uterine Cervical Neoplasms (diagnosis, pathology, virology)
  • Young Adult
  • Uterine Cervical Dysplasia (diagnosis, pathology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: